Recent trials show that overweight or obese patients saw a 14.9% reduction in body weight after taking once-weekly semaglutide 2.4 mg for 68 weeks, compared to a 2.4% reduction in body weight for the control [24]
GLP-1RAs in nervous system In the nervous system, GLP-1 can decrease oxidative stress and inflammatory responses, potentially through reducing the generation of ROS and decreasing the expression of inflammatory cytokines
With a market cap of over $500 billion, the Danish pharmaceutical giant is now Europes most valuable company
3 OT2 OD025315
It decreases leptin, the satiety hormone, by a similar amount
Fatima Cody Stanford, an associate professor of medicine and pediatrics and obesity medicine physician-scientist at the Massachusetts General Hospital and Harvard Medical School, said that as someone who has treated more than 3,000 patients with obesity, she does have strong data supporting the heterogeneity of response to GLP-1R agonists in practice